A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease

Ryo Tanaka; Takamasa Nukui; Mamoru Yamamoto; Shojiro Ichimata; Chisato Tamai; Jun Sone; Kyo Noguchi; Shunya Nakane; Yuji Nakatsuji

doi:10.1111/ncn3.12876

A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease

Ryo Tanaka, Takamasa Nukui, Mamoru Yamamoto, Shojiro Ichimata, Chisato Tamai, Jun Sone, Kyo Noguchi, Shunya Nakane^*, Yuji Nakatsuji

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

A 62-year-old man experienced lower left blindness lasting 30 min to 1 h for 5 years. Treatment with lomerizine decreased its frequency. Subsequently, he was diagnosed with neuronal intranuclear inclusion disease by histological and genetic analysis. We consider two possibilities as follows: the visual symptoms are due to NIID and the visual symptoms and NIID are completely independent conditions that have coexisted by chance. The preventive effect of lomerizine on visual symptoms lasted for about 20 months from the start of treatment until his accidental death.

Original language	English
Pages (from-to)	201-204
Number of pages	4
Journal	Neurology and Clinical Neuroscience
Volume	13
Issue number	3
DOIs	https://doi.org/10.1111/ncn3.12876
State	Published - 2025/05

Keywords

aura
lomerizine
migraine
neuronal intranuclear inclusion disease (NIID)

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1111/ncn3.12876

Cite this

@article{5603f0e7c69441bc8ad48f1a67268f6c,

title = "A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease",

abstract = "A 62-year-old man experienced lower left blindness lasting 30 min to 1 h for 5 years. Treatment with lomerizine decreased its frequency. Subsequently, he was diagnosed with neuronal intranuclear inclusion disease by histological and genetic analysis. We consider two possibilities as follows: the visual symptoms are due to NIID and the visual symptoms and NIID are completely independent conditions that have coexisted by chance. The preventive effect of lomerizine on visual symptoms lasted for about 20 months from the start of treatment until his accidental death.",

keywords = "aura, lomerizine, migraine, neuronal intranuclear inclusion disease (NIID)",

author = "Ryo Tanaka and Takamasa Nukui and Mamoru Yamamoto and Shojiro Ichimata and Chisato Tamai and Jun Sone and Kyo Noguchi and Shunya Nakane and Yuji Nakatsuji",

note = "Publisher Copyright: {\textcopyright} 2025 Japanese Society of Neurology and John Wiley & Sons Australia, Ltd.",

year = "2025",

month = may,

doi = "10.1111/ncn3.12876",

language = "英語",

volume = "13",

pages = "201--204",

journal = "Neurology and Clinical Neuroscience",

issn = "2049-4173",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease

AU - Tanaka, Ryo

AU - Nukui, Takamasa

AU - Yamamoto, Mamoru

AU - Ichimata, Shojiro

AU - Tamai, Chisato

AU - Sone, Jun

AU - Noguchi, Kyo

AU - Nakane, Shunya

AU - Nakatsuji, Yuji

PY - 2025/5

Y1 - 2025/5

N2 - A 62-year-old man experienced lower left blindness lasting 30 min to 1 h for 5 years. Treatment with lomerizine decreased its frequency. Subsequently, he was diagnosed with neuronal intranuclear inclusion disease by histological and genetic analysis. We consider two possibilities as follows: the visual symptoms are due to NIID and the visual symptoms and NIID are completely independent conditions that have coexisted by chance. The preventive effect of lomerizine on visual symptoms lasted for about 20 months from the start of treatment until his accidental death.

AB - A 62-year-old man experienced lower left blindness lasting 30 min to 1 h for 5 years. Treatment with lomerizine decreased its frequency. Subsequently, he was diagnosed with neuronal intranuclear inclusion disease by histological and genetic analysis. We consider two possibilities as follows: the visual symptoms are due to NIID and the visual symptoms and NIID are completely independent conditions that have coexisted by chance. The preventive effect of lomerizine on visual symptoms lasted for about 20 months from the start of treatment until his accidental death.

KW - aura

KW - lomerizine

KW - migraine

KW - neuronal intranuclear inclusion disease (NIID)

UR - http://www.scopus.com/inward/record.url?scp=105003397126&partnerID=8YFLogxK

U2 - 10.1111/ncn3.12876

DO - 10.1111/ncn3.12876

M3 - 学術論文

AN - SCOPUS:105003397126

SN - 2049-4173

VL - 13

SP - 201

EP - 204

JO - Neurology and Clinical Neuroscience

JF - Neurology and Clinical Neuroscience

IS - 3

ER -

A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this